e-learning
resources
ERS Research Seminars
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An example: Eosinophilic airway inflammation as a treatable trait
M. Bafadhel (Oxford, United Kingdom)
Source:
ERS Research Seminar 2017 – Precision medicine in airway diseases
Number:
3
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bafadhel (Oxford, United Kingdom). An example: Eosinophilic airway inflammation as a treatable trait. ERS Research Seminar 2017 – Precision medicine in airway diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Roberto Enrique Díaz García - 19.08.2017 03:22
Excellent
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Eosinophilic inflammation and asthma control
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009
Modulation of Eosinophilic airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011
Eosinophilic inflammation and muscle mass in chronic airway disease
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Bronchiectasis and airway eosinophilia in severe asthma—is there an association?
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Source: Eur Respir J 2008; 31: 396-406
Year: 2008
Eosinophilic lung diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Eosinophilic lung diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Eosinophilic lung diseases
Source: ERS Skills Course 2016
Year: 2016
Eosinophilic lung diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept